Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma
- 27 August 2018
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 115 (37), 9282-9287
- https://doi.org/10.1073/pnas.1807155115
Abstract
E-type cyclins E1 (CcnE1) and E2 (CcnE2) are regulatory subunits of cyclin-dependent kinase 2 (Cdk2) and thought to control the transition of quiescent cells into the cell cycle. Initial findings indicated that CcnE1 and CcnE2 have largely overlapping functions for cancer development in several tumor entities including hepatocellular carcinoma (HCC). In the present study, we dissected the differential contributions of CcnE1, CcnE2, and Cdk2 for initiation and progression of HCC in mice and patients. To this end, we tested the HCC susceptibility in mice with constitutive deficiency for CcnE1 or CcnE2 as well as in mice lacking Cdk2 in hepatocytes. Genetic inactivation of CcnE1 largely prevented development of liver cancer in mice in two established HCC models, while ablation of CcnE2 had no effect on hepatocarcinogenesis. Importantly, CcnE1-driven HCC initiation was dependent on Cdk2. However, isolated primary hepatoma cells typically acquired independence on CcnE1 and Cdk2 with increasing progression in vitro, which was associated with a gene signature involving secondary induction of CcnE2 and up-regulation of cell cycle and DNA repair pathways. Importantly, a similar expression profile was also found in HCC patients with elevated CcnE2 expression and poor survival. In general, overall survival in HCC patients was synergistically affected by expression of CcnE1 and CcnE2, but not through Cdk2. Our study suggests that HCC initiation specifically depends on CcnE1 and Cdk2, while HCC progression requires expression of any E-cyclin, but no Cdk2.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (LI2045/2-4)
- Deutsche Forschungsgemeinschaft (SFB/TRR57)
- Deutsche Forschungsgemeinschaft (NE2128/2-1)
- Ramón y Cajal fellowship (RYC2015-17438)
- Ramón y Cajal fellowship (RYC-2014-15242)
- Interdisciplinary Center for Clinical Research (IZKF) Aachen (IZKF/O3-4)
- Interdisciplinary Center for Clinical Research (IZKF) Aach (IZKF/E7-6)
- Interdisciplinary Center for Clinical Research (IZKF) Aach (IZKF/O3-3)
This publication has 23 references indexed in Scilit:
- The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple RegulationsCancers, 2014
- Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Nucleophosmin (NPM1/B23) Interacts with Activating Transcription Factor 5 (ATF5) Protein and Promotes Proteasome- and Caspase-dependent ATF5 Degradation in Hepatocellular Carcinoma CellsOnline Journal of Public Health Informatics, 2012
- Cyclin E Constrains Cdk5 Activity to Regulate Synaptic Plasticity and Memory FormationDevelopmental Cell, 2011
- Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 ActivationCancer Cell, 2010
- Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancerCell Division, 2010
- Aberrant Cell Cycle Progression and Endoreplication in Regenerating Livers of Mice That Lack a Single E-Type CyclinGastroenterology, 2009
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in miceNature Genetics, 2003
- Interaction of c-myc with transforming growth factor α and hepatocyte growth factor in hepatocarcinogenesisMutation research. Reviews in mutation research, 1997